Skip to main content
Top
Published in: Abdominal Radiology 4/2020

01-04-2020 | Magnetic Resonance Imaging | Review

Imaging and implications of tumor thrombus in abdominal malignancies: reviewing the basics

Authors: Khaled Y. Elbanna, Korosh Khalili, Martin O’Malley, Tanya Chawla

Published in: Abdominal Radiology | Issue 4/2020

Login to get access

Abstract

Extension of tumor tissue within a vein is a recognized prognostic factor in abdominal malignancy because of its influence on tumor staging and selection of therapeutic management. With the advent of newer surgical techniques, and variable treatment strategies, imaging plays a crucial role in categorizing patients according to the tumor resectability and vascular reconstruction techniques during surgery. Understanding the clinical impact of tumor thrombus increases the awareness of the radiologist about the key findings in tumor staging and decision-making of surgical approach. Ultrasound (US), computed tomography (CT), and magnetic resonance imaging (MRI) can be used individually and in combination to accurately assess the tumor thrombus. In our pictorial review, we will discuss the imaging findings and clinical consequences of tumor thrombosis in abdominal malignancies, including hepatocellular carcinoma, pancreatic neuroendocrine tumor, renal cancer, and adrenal cortical carcinoma.
Literature
1.
go back to reference Yerdel MA, Gunson B, Mirza D, et al. (2000) PORTAL VEIN THROMBOSIS IN ADULTS UNDERGOING LIVER TRANSPLANTATION: Risk Factors, Screening, Management, and Outcome1. Transplantation 69:1873–1881CrossRef Yerdel MA, Gunson B, Mirza D, et al. (2000) PORTAL VEIN THROMBOSIS IN ADULTS UNDERGOING LIVER TRANSPLANTATION: Risk Factors, Screening, Management, and Outcome1. Transplantation 69:1873–1881CrossRef
4.
go back to reference Stuart KE, Anand AJ, Jenkins RL (1996) Hepatocellular carcinoma in the United States: prognostic features, treatment outcome, and survival. Pilot clinical trial of localized concurrent chemoradiation therapy for locally advanced hepatocellular carcinoma with portal vein thrombosis 77:2217–2222 Stuart KE, Anand AJ, Jenkins RL (1996) Hepatocellular carcinoma in the United States: prognostic features, treatment outcome, and survival. Pilot clinical trial of localized concurrent chemoradiation therapy for locally advanced hepatocellular carcinoma with portal vein thrombosis 77:2217–2222
5.
go back to reference Minagawa M, Makuuchi M, Takayama T, Ohtomo K (2001) Selection criteria for hepatectomy in patients with hepatocellular carcinoma and portal vein tumor thrombus. Annals of Surgery 233(3):379CrossRef Minagawa M, Makuuchi M, Takayama T, Ohtomo K (2001) Selection criteria for hepatectomy in patients with hepatocellular carcinoma and portal vein tumor thrombus. Annals of Surgery 233(3):379CrossRef
9.
go back to reference Portolani N, Coniglio A, Ghidoni S, et al. (2006) Early and late recurrence after liver resection for hepatocellular carcinoma: prognostic and therapeutic implications. Early and late recurrence after liver resection for hepatocellular carcinoma: prognostic and therapeutic implications 243:229 Portolani N, Coniglio A, Ghidoni S, et al. (2006) Early and late recurrence after liver resection for hepatocellular carcinoma: prognostic and therapeutic implications. Early and late recurrence after liver resection for hepatocellular carcinoma: prognostic and therapeutic implications 243:229
10.
go back to reference Piscaglia F, Gianstefani A, Ravaioli M, et al (2010) Criteria for diagnosing benign portal vein thrombosis in the assessment of patients with cirrhosis and hepatocellular carcinom for liver transplantation. Liver Transpl 16:NA–NA. https://doi.org/10.1002/lt.22044 Piscaglia F, Gianstefani A, Ravaioli M, et al (2010) Criteria for diagnosing benign portal vein thrombosis in the assessment of patients with cirrhosis and hepatocellular carcinom for liver transplantation. Liver Transpl 16:NA–NA. https://​doi.​org/​10.​1002/​lt.​22044
12.
go back to reference Yamada R, Sato M, Kawabata M, et al. (1983) Hepatic artery embolization in 120 patients with unresectable hepatoma. Radiology 148:397–401CrossRef Yamada R, Sato M, Kawabata M, et al. (1983) Hepatic artery embolization in 120 patients with unresectable hepatoma. Radiology 148:397–401CrossRef
13.
go back to reference Chung JW, Park JH, Han JK, et al. (1996) Hepatic tumors: predisposing factors for complications of transcatheter oily chemoembolization. Radiology 198:33–40CrossRef Chung JW, Park JH, Han JK, et al. (1996) Hepatic tumors: predisposing factors for complications of transcatheter oily chemoembolization. Radiology 198:33–40CrossRef
14.
go back to reference Lee H-S, Kim JS, Choi IJ, et al. (1997) The safety and efficacy of transcatheter arterial chemoembolization in the treatment of patients with hepatocellular carcinoma and main portal vein obstruction. Pilot clinical trial of localized concurrent chemoradiation therapy for locally advanced hepatocellular carcinoma with portal vein thrombosis 79:2087–2094 Lee H-S, Kim JS, Choi IJ, et al. (1997) The safety and efficacy of transcatheter arterial chemoembolization in the treatment of patients with hepatocellular carcinoma and main portal vein obstruction. Pilot clinical trial of localized concurrent chemoradiation therapy for locally advanced hepatocellular carcinoma with portal vein thrombosis 79:2087–2094
19.
go back to reference Jha RC, Khera SS, Kalaria AD (2018) Portal Vein Thrombosis: Imaging the Spectrum of Disease With an Emphasis on MRI Features. American Journal of Roentgenology 211(1):14–24CrossRef Jha RC, Khera SS, Kalaria AD (2018) Portal Vein Thrombosis: Imaging the Spectrum of Disease With an Emphasis on MRI Features. American Journal of Roentgenology 211(1):14–24CrossRef
20.
go back to reference Ricci P, Cantisani V, Biancari F, et al. (2000) CONTRAST-ENHANCED COLOR DOPPLER US IN MALIGNANT PORTAL VEIN THROMBOSIS. Acta radiologica 41:470–473CrossRef Ricci P, Cantisani V, Biancari F, et al. (2000) CONTRAST-ENHANCED COLOR DOPPLER US IN MALIGNANT PORTAL VEIN THROMBOSIS. Acta radiologica 41:470–473CrossRef
21.
go back to reference Claudon M, Dietrich CF, Choi BI, et al. (2013) Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) in the liver–update 2012: a WFUMB-EFSUMB initiative in cooperation with representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUS. Ultrasound in Medicine and Biology 39:187–210CrossRef Claudon M, Dietrich CF, Choi BI, et al. (2013) Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) in the liver–update 2012: a WFUMB-EFSUMB initiative in cooperation with representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUS. Ultrasound in Medicine and Biology 39:187–210CrossRef
23.
go back to reference Sorrentino P, D’Angelo S, Tarantino L, et al. (2009) Contrast-enhanced sonography versus biopsy for the differential diagnosis of thrombosis in hepatocellular carcinoma patients. World Journal of Gastroenterology: WJG 15:2245CrossRef Sorrentino P, D’Angelo S, Tarantino L, et al. (2009) Contrast-enhanced sonography versus biopsy for the differential diagnosis of thrombosis in hepatocellular carcinoma patients. World Journal of Gastroenterology: WJG 15:2245CrossRef
24.
go back to reference Piscaglia F, Wilson SR, Lyshchik A, et al. (2017) American College of Radiology Contrast Enhanced Ultrasound Liver Imaging Reporting and Data System (CEUS LI-RADS) for the diagnosis of hepatocellular carcinoma: a pictorial essay. Ultraschall in der Medizin-European Journal of Ultrasound 38:320–324CrossRef Piscaglia F, Wilson SR, Lyshchik A, et al. (2017) American College of Radiology Contrast Enhanced Ultrasound Liver Imaging Reporting and Data System (CEUS LI-RADS) for the diagnosis of hepatocellular carcinoma: a pictorial essay. Ultraschall in der Medizin-European Journal of Ultrasound 38:320–324CrossRef
25.
go back to reference Wilson SR, Lyshchik A, Piscaglia F, et al. (2018) CEUS LI-RADS: algorithm, implementation, and key differences from CT/MRI. Contrast-enhanced ultrasound of malignant liver lesions 43:127–142 Wilson SR, Lyshchik A, Piscaglia F, et al. (2018) CEUS LI-RADS: algorithm, implementation, and key differences from CT/MRI. Contrast-enhanced ultrasound of malignant liver lesions 43:127–142
26.
go back to reference Goettler CE, Stallion A, Grisoni ER, Dudgeon DL (2002) Delayed hemorrhage after blunt hepatic trauma: case report. Journal of Trauma and Acute Care Surgery 52:556–559CrossRef Goettler CE, Stallion A, Grisoni ER, Dudgeon DL (2002) Delayed hemorrhage after blunt hepatic trauma: case report. Journal of Trauma and Acute Care Surgery 52:556–559CrossRef
28.
go back to reference Tublin ME, Dodd GD 3rd, Baron RL (1997) Benign and malignant portal vein thrombosis: differentiation by CT characteristics. American Journal of Roentgenology 168:719–723CrossRef Tublin ME, Dodd GD 3rd, Baron RL (1997) Benign and malignant portal vein thrombosis: differentiation by CT characteristics. American Journal of Roentgenology 168:719–723CrossRef
30.
go back to reference Qian LJ, Zhu J, Zhuang ZG, et al. (2012) Differentiation of neoplastic from bland macroscopic portal vein thrombi using dual-energy spectral CT imaging: a pilot study. Eur Radiol 22:2178–2185CrossRef Qian LJ, Zhu J, Zhuang ZG, et al. (2012) Differentiation of neoplastic from bland macroscopic portal vein thrombi using dual-energy spectral CT imaging: a pilot study. Eur Radiol 22:2178–2185CrossRef
32.
go back to reference Ahn J-H, Yu J-S, Cho E-S, et al. (2016) Diffusion-Weighted MRI of Malignant versus Benign Portal Vein Thrombosis. Korean J Radiol 17:533–540CrossRef Ahn J-H, Yu J-S, Cho E-S, et al. (2016) Diffusion-Weighted MRI of Malignant versus Benign Portal Vein Thrombosis. Korean J Radiol 17:533–540CrossRef
34.
go back to reference Birnbaum DJ, Turrini O, Ewald J, et al. (2014) Pancreatic neuroendocrine tumor: A multivariate analysis of factors influencing survival. European Journal of Surgical Oncology (EJSO) 40:1564–1571CrossRef Birnbaum DJ, Turrini O, Ewald J, et al. (2014) Pancreatic neuroendocrine tumor: A multivariate analysis of factors influencing survival. European Journal of Surgical Oncology (EJSO) 40:1564–1571CrossRef
35.
go back to reference Wang S-E, Su C-H, Kuo Y-J, et al. (2011) Comparison of Functional and Nonfunctional Neuroendocrine Tumors in the Pancreas and Peripancreatic Region. Pancreas 40:253CrossRef Wang S-E, Su C-H, Kuo Y-J, et al. (2011) Comparison of Functional and Nonfunctional Neuroendocrine Tumors in the Pancreas and Peripancreatic Region. Pancreas 40:253CrossRef
36.
go back to reference Prakash L, Lee JE, Yao J, et al. (2015) Role and Operative Technique of Portal Venous Tumor Thrombectomy in Patients with Pancreatic Neuroendocrine Tumors. Journal of Gastrointestinal Surgery 19:2011–2018CrossRef Prakash L, Lee JE, Yao J, et al. (2015) Role and Operative Technique of Portal Venous Tumor Thrombectomy in Patients with Pancreatic Neuroendocrine Tumors. Journal of Gastrointestinal Surgery 19:2011–2018CrossRef
37.
go back to reference Balachandran A, Tamm EP, Bhosale PR, et al. (2012) Venous tumor thrombus in nonfunctional pancreatic neuroendocrine tumors. American Journal of Roentgenology 199:602–608CrossRef Balachandran A, Tamm EP, Bhosale PR, et al. (2012) Venous tumor thrombus in nonfunctional pancreatic neuroendocrine tumors. American Journal of Roentgenology 199:602–608CrossRef
38.
go back to reference Robertis RD, Paiella S, Cardobi N, et al. (2018) Tumor thrombosis: a peculiar finding associated with pancreatic neuroendocrine neoplasms. A pictorial essay. Contrast-enhanced ultrasound of malignant liver lesions 43:613–619 Robertis RD, Paiella S, Cardobi N, et al. (2018) Tumor thrombosis: a peculiar finding associated with pancreatic neuroendocrine neoplasms. A pictorial essay. Contrast-enhanced ultrasound of malignant liver lesions 43:613–619
39.
go back to reference Semelka RC, Custodio CM, Balci NC, Woosley JT (2000) Neuroendocrine tumors of the pancreas: spectrum of appearances on MRI. Journal of Magnetic Resonance Imaging: An Official Journal of the International Society for Magnetic Resonance in Medicine 11:141–148CrossRef Semelka RC, Custodio CM, Balci NC, Woosley JT (2000) Neuroendocrine tumors of the pancreas: spectrum of appearances on MRI. Journal of Magnetic Resonance Imaging: An Official Journal of the International Society for Magnetic Resonance in Medicine 11:141–148CrossRef
40.
41.
go back to reference Psutka SP, Boorjian SA, Thompson RH, et al. (2015) Clinical and radiographic predictors of the need for inferior vena cava resection during nephrectomy for patients with renal cell carcinoma and caval tumour thrombus. BJU Int 116:388–396CrossRef Psutka SP, Boorjian SA, Thompson RH, et al. (2015) Clinical and radiographic predictors of the need for inferior vena cava resection during nephrectomy for patients with renal cell carcinoma and caval tumour thrombus. BJU Int 116:388–396CrossRef
42.
go back to reference Tilki D, Nguyen HG, Dall’Era MA, et al. (2014) Impact of histologic subtype on cancer-specific survival in patients with renal cell carcinoma and tumor thrombus. European Urology 66:577–583CrossRef Tilki D, Nguyen HG, Dall’Era MA, et al. (2014) Impact of histologic subtype on cancer-specific survival in patients with renal cell carcinoma and tumor thrombus. European Urology 66:577–583CrossRef
43.
go back to reference Kondo T, Ikezawa E, Takagi T, et al. (2013) Negative impact of papillary histological subtype in patients with renal cell carcinoma extending into the inferior vena cava: Single-center experience. International Journal of Urology 20:1072–1077CrossRef Kondo T, Ikezawa E, Takagi T, et al. (2013) Negative impact of papillary histological subtype in patients with renal cell carcinoma extending into the inferior vena cava: Single-center experience. International Journal of Urology 20:1072–1077CrossRef
44.
go back to reference Dunnick NR (2016) Renal cell carcinoma: staging and surveillance. Contrast-enhanced ultrasound of malignant liver lesions 41:1079–1085 Dunnick NR (2016) Renal cell carcinoma: staging and surveillance. Contrast-enhanced ultrasound of malignant liver lesions 41:1079–1085
45.
go back to reference Robins DJ, Small AC, Amin MB, et al. (2017) MP86-17 the 2017 American Joint Committee on Cancer eighth edition cancer staging manual: changes in staging guidelines for cancers of the kidney, renal pelvis and ureter, bladder, and urethra. The Journal of Urology 197:e1163CrossRef Robins DJ, Small AC, Amin MB, et al. (2017) MP86-17 the 2017 American Joint Committee on Cancer eighth edition cancer staging manual: changes in staging guidelines for cancers of the kidney, renal pelvis and ureter, bladder, and urethra. The Journal of Urology 197:e1163CrossRef
51.
go back to reference Lawrentschuk N, Gani J, Riordan R, et al. (2005) Multidetector computed tomography vs magnetic resonance imaging for defining the upper limit of tumour thrombus in renal cell carcinoma: a study and review. BJU Int 96:291–295CrossRef Lawrentschuk N, Gani J, Riordan R, et al. (2005) Multidetector computed tomography vs magnetic resonance imaging for defining the upper limit of tumour thrombus in renal cell carcinoma: a study and review. BJU Int 96:291–295CrossRef
54.
go back to reference Ng L, Libertino JM (2003) Adrenocortical carcinoma: diagnosis, evaluation and treatment. The Journal of Urology 169:5–11CrossRef Ng L, Libertino JM (2003) Adrenocortical carcinoma: diagnosis, evaluation and treatment. The Journal of Urology 169:5–11CrossRef
55.
go back to reference Smillie RP, Shetty M, Boyer AC, et al. (2015) Imaging evaluation of the inferior vena cava. RadioGraphics 35:578–592CrossRef Smillie RP, Shetty M, Boyer AC, et al. (2015) Imaging evaluation of the inferior vena cava. RadioGraphics 35:578–592CrossRef
56.
go back to reference Chiche L, Dousset B, Kieffer E, Chapuis Y (2006) Adrenocortical carcinoma extending into the inferior vena cava: presentation of a 15-patient series and review of the literature. Surgery 139:15–27CrossRef Chiche L, Dousset B, Kieffer E, Chapuis Y (2006) Adrenocortical carcinoma extending into the inferior vena cava: presentation of a 15-patient series and review of the literature. Surgery 139:15–27CrossRef
57.
go back to reference Laan DV, Thiels CA, Glasgow A, et al. (2017) Adrenocortical carcinoma with inferior vena cava tumor thrombus. Surgery 161:240–248CrossRef Laan DV, Thiels CA, Glasgow A, et al. (2017) Adrenocortical carcinoma with inferior vena cava tumor thrombus. Surgery 161:240–248CrossRef
58.
go back to reference Bharwani N, Rockall AG, Sahdev A, et al. (2011) Adrenocortical carcinoma: the range of appearances on CT and MRI. American Journal of Roentgenology 196:W706–W714CrossRef Bharwani N, Rockall AG, Sahdev A, et al. (2011) Adrenocortical carcinoma: the range of appearances on CT and MRI. American Journal of Roentgenology 196:W706–W714CrossRef
Metadata
Title
Imaging and implications of tumor thrombus in abdominal malignancies: reviewing the basics
Authors
Khaled Y. Elbanna
Korosh Khalili
Martin O’Malley
Tanya Chawla
Publication date
01-04-2020

Other articles of this Issue 4/2020

Abdominal Radiology 4/2020 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.